NIH Weekly Funding Opportunities and Policy Notices

Wednesday, March 27, 2024 - 11:15pm
Funding Opportunity PAR-24-137 from the NIH Guide for Grants and Contracts. The goal of the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D). This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for the completion of research-focused higher degree programs in biomedical fields. This program is limited to applications from training programs at research-active institutions (i.e., those with a 3-year average of NIH Research Project Grant funding less than $7.5 million total costs).
Wednesday, March 27, 2024 - 9:24am
Notice NOT-OD-24-077 from the NIH Guide for Grants and Contracts
Wednesday, March 27, 2024 - 9:23am
Funding Opportunity PAR-24-169 from the NIH Guide for Grants and Contracts. This notice of opportunity announcement (NOFO) is issued by the National Institute of Neurological Disorders and Stroke to enable submission of program project grant applications that propose to conduct innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.
Wednesday, March 27, 2024 - 1:14am
Funding Opportunity RFA-AI-24-008 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support product-focused research to advance controlled release vaccine strategies to improve immune responses for HIV prevention, treatment, and cure and develop simplified or single-shot vaccination formulations. Timelines with measurable milestones are required.
Wednesday, March 27, 2024 - 1:10am
Funding Opportunity RFA-AI-24-010 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries. Evaluation studies should: 1) perform proof-of principle studies of novel diagnostic tests and strategies for TB, including among people living with HIV (PLWH) and 2) provide feedback to diagnostic developers and policy makers on the performance of the technologies and most effective strategies for use of the diagnostic technologies in an endemic setting.
Wednesday, March 27, 2024 - 1:10am
Funding Opportunity RFA-CA-24-020 from the NIH Guide for Grants and Contracts. The purpose of the U54 CHD-MH SPORE Program is to fund a network of multi-disciplinary, multi-institutional translational research SPOREs uniquely focused on 1) health disparities and/or minority health research and 2) the development of novel-cancer relevant interventions in underserved populations with cancer or at risk for cancer.
Wednesday, March 27, 2024 - 1:09am
Funding Opportunity RFA-AI-24-006 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to invite applications for Research Centers (RC) to support the Centers for Research in Emerging Infectious Diseases (CREID) Network. The CREID network serves to expand knowledge on re-emerging and emerging infectious diseases (re/EIDs) around the globe where outbreaks are most likely to occur. Multi- and inter-disciplinary teams of domestic and international investigators will conduct innovative, collaborative One Health (approach that recognizes the health of humans is interconnected with that of animal health and the shared environment) based research projects and will mount a rapid and effective research response to outbreaks through coordination, collaboration, and cooperation across the CREID Network.
Wednesday, March 27, 2024 - 12:11am
Notice NOT-OD-24-078 from the NIH Guide for Grants and Contracts
Wednesday, March 27, 2024 - 12:10am
Notice NOT-AI-24-028 from the NIH Guide for Grants and Contracts
Wednesday, March 27, 2024 - 12:10am
Funding Opportunity RFA-AI-24-016 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to invite applications for the Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (CC). The CREID Network, comprised of all recipients under this NOFO and the companion NOFO [insert NOFO number here], serves to expand knowledge on re-emerging and emerging infectious diseases (re/EIDs) around the globe where outbreaks are most likely to occur while developing expertise, capacity, and readiness to address outbreak-related research. The CC will serve to advance, facilitate, and coordinate select scientific, data and resource management, communication, administrative, and leadership efforts during both outbreak and non-outbreak periods among the CREID Networks centers and stakeholders in a collaborative and cooperative fashion.
Tuesday, March 26, 2024 - 10:56am
Funding Opportunity RFA-NS-25-012 from the NIH Guide for Grants and Contracts. This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).
Tuesday, March 26, 2024 - 6:36am
Notice NOT-OD-24-079 from the NIH Guide for Grants and Contracts
Monday, March 25, 2024 - 10:48am
Notice NOT-MH-24-165 from the NIH Guide for Grants and Contracts

Pages